相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cells
Soumya V. Nair et al.
CHEMICAL COMMUNICATIONS (2015)
High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection
Julien Autebert et al.
LAB ON A CHIP (2015)
Solid-phase extraction and purification of membrane proteins using a UV-modified PMMA microfluidic bioaffinity μSPE device
Katrina N. Battle et al.
ANALYST (2014)
Parallel Affinity-Based Isolation of Leukocyte Subsets Using Microfluidics: Application for Stroke Diagnosis
Swathi R. Pullagurla et al.
ANALYTICAL CHEMISTRY (2014)
Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for prime time?
David Grimwade et al.
BLOOD (2014)
Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future
J. M. Jaso et al.
BONE MARROW TRANSPLANTATION (2014)
Arrays of high-aspect ratio microchannels for high-throughput isolation of circulating tumor cells (CTCs)
Mateusz L. Hupert et al.
MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS (2014)
UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection
Joshua M. Jackson et al.
LAB ON A CHIP (2014)
Size-selective collection of circulating tumor cells using Vortex technology
Elodie Sollier et al.
LAB ON A CHIP (2014)
Modular Microsystem for the Isolation, Enumeration, and Phenotyping of Circulating Tumor Cells in Patients with Pancreatic Cancer
J. W. Kamande et al.
ANALYTICAL CHEMISTRY (2013)
Recent advances in acute myeloid leukemia stem cell biology
Sarah J. Horton et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
Ahmet H. Elmaagacli et al.
BLOOD (2011)
Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation
Betul Oran et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
V. H. J. van der Velden et al.
LEUKEMIA (2010)
Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?
Gerrit Jan Schuurhuis et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
The Role of Multiparameter Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
Adhra Al-Mawali et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells
Geneve Awong et al.
BLOOD (2009)
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
Susanne Schnittger et al.
BLOOD (2009)
Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor
Andre A. Adams et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
What do we mean by sensitivity when we talk about detecting minimal residual disease?
D. Steinbach et al.
LEUKEMIA (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rare-event analysis in flow cytometry
Albert D. Donnenberg et al.
CLINICS IN LABORATORY MEDICINE (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
Statistical considerations for enumeration of circulating tumor cells
Arjan G. J. Tibbe et al.
CYTOMETRY PART A (2007)
Evaluation of micromilled metal mold masters for the replication of microchip electrophoresis devices
Mateusz L. Hupert et al.
MICROFLUIDICS AND NANOFLUIDICS (2007)
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
P. K. Y. Goon et al.
NEOPLASIA (2006)
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation
R Zeiser et al.
LEUKEMIA (2005)
Prognostic index for adult patients with acute myeloid leukemia in first relapse
DA Breems et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
B-cell lymphomas with coexpression of CD5 and CD10
HY Dong et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
High frequency of immunophenotype changes in acute myeloid leukemia at relapse:: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
MR Baer et al.
BLOOD (2001)
分享论文
